What is PYXS's dilution risk score?

PYXS has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PYXS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PYXS?

DilutionWatch tracks 25 SEC filing types for PYXS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PYXS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PYXS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PYXS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PYXS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PYXS Dilution Risk Score: 65/100 (HIGH)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

85

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 35%

🔄 Reverse Split model est. 45%

• 50-day avg $1.79 approaching $1 threshold

• Only 4 months cash — financial pressure

💰 Capital Raise model 35%

• Low cash runway: 4 months remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (65/100)

🔔 Track PYXS — Get forecast alerts →

Market Data

Market Cap$114.04M

Shares Outstanding83.41M

Float40.40M

Cash$33.00M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↓ 12.4% shares (2026Q1 vs prior)

77 institutional holders · 31.46M shares

#1 Pfizer Inc 7.03M shares

#2 Laurion Capital Management LP 5.00M shares

#3 GordonMD Global Investments LP 4.12M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.17M

Days to Cover4.2

% of Float10.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2021-12-31

4 INSIDER TRANSACTION 2026-03-25

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PYXS Dilution Snapshot

Pyxis Oncology, Inc. (PYXS) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for PYXS: xbrl on 2026-06-30; 4 on 2026-03-25; 4 on 2026-03-25.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.